Assisted Living Facility and Neurorehabilitation Market Report 2025

This Assisted Living Facility and Neurorehabilitation market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The assisted living facility and neurorehabilitation market size has grown strongly in recent years. It will grow from $47.63 billion in 2024 to $51.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to growing geriatric population demands, demand for neurorehabilitation centers, gaining traction of continuing-care retirement communities, and increasing number of traumatic brain injury (TBI) survivors.

The assisted living facility and neurorehabilitation market size is expected to see strong growth in the next few years. It will grow to $69.74 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the need for neurorehabilitation devices, rising incidence and prevalence of neurological disorders, growing income from the senior population, and the desire to live in senior housing communities for better healthcare. Major trends in the forecast period include advancements in medicine and technology, the adoption of computer-aided and electronic robotic devices, adoption of newer treatments at a fast rate, and technological advancements.

The increasing demand for personalized senior care services is expected to drive the growth of the assisted living facility and neurorehabilitation market. Personalized senior care services encompass a wide range of offerings aimed at helping elderly individuals maintain independence and quality of life. This demand is rising due to the growing elderly population, their distinct care needs, and the desire for high-quality services. By integrating assisted living facilities with neurorehabilitation, personalized senior care services provide comprehensive support that combines daily living assistance with specialized therapeutic interventions addressing individual neurological needs. For example, in March 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that government spending on aged care totaled $24.8 billion in 2021-22. With the aging population, this spending is projected to increase from 1.1% of GDP in 2021-22 to 2.5% by 2062-63. Therefore, the growing demand for personalized senior care services is fueling the expansion of the assisted living facility and neurorehabilitation market.

Key players in the assisted living facilities and neurorehabilitation market are directing their focus towards technological advancements, such as smart peripheral devices, to gain a competitive advantage. These devices are highly sensitive controllers capable of capturing fine grasp forces and wrist movements required for daily activities. They can detect even sub-newton-level finger and hand forces, facilitating treatment for patients with varying degrees of impairment. For example, MindMaze, a Switzerland-based digital therapeutics company, introduced Izar in February 2023, a groundbreaking smart peripheral device approved by the FDA and CE-marked for patients with impaired hand motor function. Izar addresses a crucial gap in neurological care, aiming to offer the most effective treatment for enhancing hand dexterity and strength across conditions such as stroke, Parkinson's disease, Alzheimer's disease, and traumatic brain injury.

In August 2024, National Healthcare Corporation (NHC), a US-based healthcare company, acquired White Oak Senior Living (White Oak) for an undisclosed amount. This acquisition marks a significant expansion of NHC's operations into a new state and a strategic enhancement of its growth within its current operational areas. White Oak Senior Living is a US-based provider of senior living and healthcare services, offering a range of care options including independent living, assisted living, and memory care.

Major companies operating in the assisted living facility and neurorehabilitation market are Community Health Systems Inc., Sevita Health, Encompass Health Corporation, Kindred Healthcare LLC, Brookdale Senior Living, Atria Senior Living Inc., SCA Health, Belmont VillAge L.P., Aegis Living, Craig Hospital, NeuroRestorative, Centre For Neuro Skills, Bioness Inc., Texas NeuroRehab Center, Catholic Eldercare, Moody Neurorehabilitation Institute, ResCare Inc., Sukino Healthcare Solutions Pvt. Ltd., TeamHealth, Mary Lee Foundation, Sanctus Rehabilitation Care Foundation.

North America was the largest region in the assisted living facility and neurorehabilitation market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the assisted living facility and neurorehabilitation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the assisted living facility and neurorehabilitation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An assisted living facility delivers residential care and supportive services for individuals requiring assistance with daily activities but not intensive medical attention. Neurorehabilitation is a specialized therapeutic approach aimed at enhancing the function and quality of life of individuals with neurological disorders or injuries. Together, these services create a comprehensive care environment where residents receive both daily living support and specialized neurological rehabilitation.

The primary types of assisted living facilities and neurorehabilitation cater to both women and men. Assisted living facilities designed specifically for women may offer tailored services and amenities to address their distinct needs and preferences, fostering a supportive environment for aging individuals or those with specific health concerns. These facilities serve various age groups, including those under 65, aged 65-74, 75-84, and over 85, with applications primarily in hospitals, clinics, personal care, and other related settings.

The assisted living facilities and neurorehabilitation market research report is one of a series of new reports that provides assisted living facilities and neurorehabilitation market statistics, including assisted living facilities and neurorehabilitation industry global market size, regional shares, competitors with a assisted living facilities and neurorehabilitation market share, detailed assisted living facilities and neurorehabilitation market segments, market trends and opportunities, and any further data you may need to thrive in the assisted living facilities and neurorehabilitation industry. This assisted living facilities and neurorehabilitation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The assisted living facility and neurorehabilitation market includes revenues earned by entities by providing services such as physical therapy, occupational therapy, speech therapy, cognitive therapy, and psychological support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.